Toxicometabolomics-based cardiotoxicity evaluation of Thiazolidinedione exposure in human-derived cardiomyocytes

被引:4
|
作者
Al Sultan, Abdullah [1 ,2 ]
Rattray, Zahra [1 ]
Rattray, Nicholas J. W. [1 ,3 ]
机构
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Scotland
[2] Kuwait Univ, Fac Pharm, Safat 13110, Kuwait
[3] Univ Strathclyde, Strathclyde Ctr Mol Biosci, Glasgow City G4 0RE, Scotland
关键词
Thiazolidinediones; Toxicometabolomics; LC-MS; Cardiotoxicity; Amino acids; Carnitines; HEART; INHIBITION;
D O I
10.1007/s11306-024-02097-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThiazolidinediones (TZDs), represented by pioglitazone and rosiglitazone, are a class of cost-effective oral antidiabetic agents posing a marginal hypoglycaemia risk. Nevertheless, observations of heart failure have hindered the clinical use of both therapies.ObjectiveSince the mechanism of TZD-induced heart failure remains largely uncharacterised, this study aimed to explore the as-yet-unidentified mechanisms underpinning TZD cardiotoxicity using a toxicometabolomics approach.MethodsThe present investigation included an untargeted liquid chromatography-mass spectrometry-based toxicometabolomics pipeline, followed by multivariate statistics and pathway analyses to elucidate the mechanism(s)of TZD-induced cardiotoxicity using AC16 human cardiomyocytes as a model, and to identify the prognostic features associated with such effects.ResultsAcute administration of either TZD agent resulted in a significant modulation in carnitine content, reflecting potential disruption of the mitochondrial carnitine shuttle. Furthermore, perturbations were noted in purine metabolism and amino acid fingerprints, strongly conveying aberrations in cardiac energetics associated with TZD usage. Analysis of our findings also highlighted alterations in polyamine (spermine and spermidine) and amino acid (L-tyrosine and valine) metabolism, known modulators of cardiac hypertrophy, suggesting a potential link to TZD cardiotoxicity that necessitates further research. In addition, this comprehensive study identified two groupings - (i) valine and creatine, and (ii) L-tryptophan and L-methionine - that were significantly enriched in the above-mentioned mechanisms, emerging as potential fingerprint biomarkers for pioglitazone and rosiglitazone cardiotoxicity, respectively.ConclusionThese findings demonstrate the utility of toxicometabolomics in elaborating on mechanisms of drug toxicity and identifying potential biomarkers, thus encouraging its application in the toxicological sciences. (245 words)
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Toxicometabolomics-based cardiotoxicity evaluation of Thiazolidinedione exposure in human-derived cardiomyocytes
    Abdullah Al Sultan
    Zahra Rattray
    Nicholas J. W. Rattray
    Metabolomics, 20
  • [2] Cytotoxicity and toxicoproteomics analysis of thiazolidinedione exposure in human-derived cardiomyocytes
    Al Sultan, Abdullah
    Rattray, Zahra
    Rattray, Nicholas J. W.
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (08) : 1214 - 1235
  • [3] Physiologic IKr augmentation in human-derived stem cell cardiomyocytes for improved cardiotoxicity drug screening
    Nowak, Mark W.
    Panama, Brian K.
    Singh, Sanjot
    Gong, Qiuming
    Rasmusson, Randall L.
    Zhou, Zhengfeng
    Bett, Glenna C. L.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [4] Cardiotoxicity evaluation of chronic BMS-986094 exposure in human iPSC-derived cardiomyocytes using a microelectrode array (MEA) assay
    Strock, Christopher J.
    Bradley, Jenifer
    Qin, Shuzhen
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 129 - 129
  • [5] Evaluation of ion channel trafficking in human stem cell-derived cardiomyocytes for cardiotoxicity screening
    Abe, Yasuyuki
    Sakakura, Tomoko
    Takasuna, Kiyoshi
    Sanbuissho, Atsushi
    Nomura, Fumimasa
    Hamada, Tomoyo
    Kaneko, Tomoyuki
    Yasuda, Kenji
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E7 - E7
  • [6] Evaluation of the cardiotoxicity potential of bisphenol analogues in human induced pluripotent stem cells derived cardiomyocytes
    Lee, Seul-Gi
    Song, Gyeong-Eun
    Seok, Jin
    Kim, Jin
    Kim, Min Woo
    Rhee, Jooeon
    Park, Shinhye
    Jeong, Kyu Sik
    Lee, Suemin
    Lee, Yun Hyeong
    Jeong, Youngin
    Chung, Hyung Min
    Kim, C-Yoon
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 272
  • [7] Evaluation of doxorubicin-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Hunault, Marion
    Legrand, Christophe
    Castagne, Vincent
    Goineau, Sonia
    TOXICOLOGY LETTERS, 2017, 280 : S255 - S255
  • [8] Establishing stable, physiological IKr expression in human-derived stem cell cardiomyocytes
    Panama, Brian K.
    Nowak, Mark W.
    Franks, Brandon
    Zhou, Zhengfeng
    Korbel, Leigh
    Bett, Glenna C.
    Rasmusson, Randall L.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [9] Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Lee, Sujeong
    Lee, Hyang-Ae
    Choi, Sung Woo
    Kim, Sung Joon
    Kim, Ki-Suk
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 296 : 42 - 53
  • [10] Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines
    D. L. Misner
    M. A. Kauss
    J. Singh
    H. Uppal
    A. Bruening-Wright
    B. M. Liederer
    T. Lin
    B. McCray
    N. La
    T. Nguyen
    D. Sampath
    P. S. Dragovich
    T. O’Brien
    T. S. Zabka
    Cardiovascular Toxicology, 2017, 17 : 307 - 318